Published in Am J Manag Care on December 01, 2010
Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses. Breast Cancer Res Treat (2013) 0.97
Far beyond the usual biomarkers in breast cancer: a review. J Cancer (2014) 0.87
Clinical utility of gene-expression profiling in women with early breast cancer: an overview of systematic reviews. Genet Med (2014) 0.82
Modern Risk Assessment for Individualizing Treatment Concepts in Early-stage Breast Cancer. Rev Obstet Gynecol (2013) 0.75
Cost-effectiveness analysis of Mammostrat® compared with Oncotype DX® to inform the treatment of breast cancer. Clinicoecon Outcomes Res (2014) 0.75
Clinical utility of gene-expression signatures in early stage breast cancer. Nat Rev Clin Oncol (2017) 0.75
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02
Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. J Clin Oncol (2004) 2.52
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer. J Clin Oncol (2012) 2.21
Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2010) 2.16
Surgical treatment patterns among Medicare beneficiaries newly diagnosed with lumbar spinal stenosis. Spine J (2010) 2.09
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer (2012) 1.85
Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol (2010) 1.84
Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Med Care (2007) 1.80
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes. J Natl Cancer Inst (2011) 1.71
Development of an activity-based costing model to evaluate physician office practice profitability. Ophthalmology (2010) 1.53
Do variations in provider discussions explain socioeconomic disparities in postmastectomy breast reconstruction? J Am Coll Surg (2008) 1.31
Measuring the improving quality of outpatient care in medical oncology practices in the United States. J Clin Oncol (2013) 1.30
Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure. Am J Respir Crit Care Med (2010) 1.27
The value of specialty oncology drugs. Health Serv Res (2009) 1.24
Surviving colorectal cancer : patient-reported symptoms 4 years after diagnosis. Cancer (2007) 1.21
Symptom management after breast cancer treatment: is it influenced by patient characteristics? Breast Cancer Res Treat (2007) 1.16
Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer. Am J Manag Care (2010) 1.15
Developing a reliable, valid, and feasible plan for quality-of-care measurement for cancer: how should we measure? Med Care (2002) 1.14
Symptoms after breast cancer treatment: are they influenced by patient characteristics? Breast Cancer Res Treat (2007) 1.12
Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication. Breast Cancer Res Treat (2012) 1.09
Cancer Quality-ASSIST supportive oncology quality indicator set: feasibility, reliability, and validity testing. Cancer (2010) 0.98
Financial incentives for quality in breast cancer care. Am J Manag Care (2008) 0.97
Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study. Cancer (2012) 0.95
Patient preference and contraindications in measuring quality of care: what do administrative data miss? J Clin Oncol (2013) 0.95
Quality of end-of-life care for patients with advanced cancer in an academic medical center. J Palliat Med (2011) 0.94
Systemic treatment in unresectable metastatic well-differentiated carcinoid tumors: consensus results from a modified delphi process. Pancreas (2013) 0.93
Quality of prostate cancer care among rural men in the Veterans Health Administration. Cancer (2013) 0.93
Documentation and discussion of preferences for care among patients with advanced cancer. J Oncol Pract (2011) 0.90
Impact of primary prophylaxis on febrile neutropenia within community practices in the US. J Med Econ (2009) 0.90
Costs and rehabilitation use of stroke survivors: a retrospective study of Medicare beneficiaries. Top Stroke Rehabil (2009) 0.87
Wrestling with the high price of cancer care: should we control costs by individuals' ability to pay or society's willingness to pay? J Clin Oncol (2010) 0.87
Physician and Practice Characteristics Influencing Tumor Board Attendance: Results From the Provider Survey of the Los Angeles Women's Health Study. J Oncol Pract (2011) 0.86
Prevalence, predictors, and patient outcomes associated with physician co-management: findings from the Los Angeles Women's Health Study. Health Serv Res (2011) 0.85
Reconsidering the Veterans Health Administration: a model and a moment for publicly funded health care delivery. Ann Intern Med (2011) 0.84
Preoperative breast MRI in early-stage breast cancer. Breast Cancer Res Treat (2012) 0.83
The structural landscape of the health care system for breast cancer care: results from the Los Angeles Women's Health Study. Breast J (2008) 0.83
Improving colorectal cancer screening rates in a managed care health plan: recruitment of provider organizations for a randomized effectiveness trial. Cancer Epidemiol Biomarkers Prev (2003) 0.83
Use of interpreters by physicians treating limited English proficient women with breast cancer: results from the provider survey of the Los Angeles Women's Health Study. Health Serv Res (2009) 0.81
Evaluation of economic efficiencies in clinical retina practice: activity-based cost analysis and modeling to determine impacts of changes in patient management. Clin Ophthalmol (2011) 0.80
Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study. BMC Cancer (2011) 0.80
When hope hinders science and patient-centered care. J Clin Oncol (2012) 0.79
Facility characteristics and quality of lung cancer care in an integrated health care system. J Thorac Oncol (2014) 0.78
The cost-quality trade-off: need for data quality standards for studies that impact clinical practice and health policy. J Clin Oncol (2005) 0.77
Bridging the divide: integrating cancer-directed therapy and palliative care. J Clin Oncol (2004) 0.77
Providing cancer care: individual or team sport? J Gen Intern Med (2012) 0.75
How might VA-Medicare differences inform the delivery of end-of-life cancer care? Cancer (2010) 0.75
Access to care is requisite but not sufficient for quality cancer care. Cancer Invest (2005) 0.75
Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy. J Natl Cancer Inst (2011) 0.75
Increasing use of advanced imaging: evidence that we need to do more to help our patients tolerate the uncertainty of living with cancer. J Oncol Pract (2014) 0.75
Cost effectiveness analysis of a next generation risk assessment score for cardiovascular disease. J Med Econ (2013) 0.75